title: Regulation of Overnutrition-Induced Cardiac Inflammatory Mechanisms.
abstract: BACKGROUND: Unlike conventional β-blockers, nebivolol, a third-generation β-adrenergic receptor blocker with vasodilator properties, promotes insulin sensitivity. Objective: The objective of this study was to determine whether nebivolol regulates overnutrition-induced activation of cardiac nutrient sensor kinases and inflammatory signaling.  METHODS: Young Zucker obese (ZO) rats, a rodent model for overnutrition, and age-matched Zucker lean rats were treated with nebivolol (10 mg/kg/day; 21 days) and cardiac function was monitored by echocardiography and pressure volume loop analysis. Activation status of nutrient sensor serine/threonine kinases mammalian target for rapamycin (mTOR), and p70 S6kinase (S6K1) and S6K1-substrate RPS6, inflammatory marker Janus kinase 2 (Jak2) and its substrate STAT1, and energy sensor AMP-dependent kinase (AMPK) were monitored by determining phosphorylation status of pSer(2448) of mTOR, pThr(389) of S6K1, pSer(235/236) of RPS6, pTyr(1007/1008) of Jak2, pTyr(701) of STAT1, and pThr(172) of AMPK, respectively.  RESULTS: Nebivolol reduced weight and improved cardiac function of ZO rats as shown by improvements in the myocardial performance index and a decrease in the diastolic parameter tau (τ), the time constant of isovolumic relaxation. Nebivolol also attenuated excessive activation of the nutrient sensor kinases mTOR and S6K1 and their substrate RPS6 as well as the inflammatory marker Jak2 and substrate STAT1 in ZO myocardium (p < 0.05). Moreover, nebivolol reversed suppression of the energy sensor kinase AMPK in ZO hearts (p < 0.05).  CONCLUSION: We report for the first time that nebivolol regulates overnutrition-induced activation of cardiac mTOR and Jak/STAT signaling and reverses suppression of AMPK. Since it also suppresses weight gain, nebivolol appears effective in the treatment of overnutrition-related cardiac inflammation and diastolic dysfunction.
authors.affiliation: Department of Internal Medicine, University of Missouri School of Medicine, Columbia, Mo., USA.
authors.forename: Rukhsana
authors.initials: R
authors.lastname: Gul
authors.forename: Vincent G
authors.initials: VG
authors.lastname: Demarco
authors.forename: James R
authors.initials: JR
authors.lastname: Sowers
authors.forename: Adam
authors.initials: A
authors.lastname: Whaley-Connell
authors.forename: Lakshmi
authors.initials: L
authors.lastname: Pulakat